三阴性乳腺癌变局来袭

新浪医药
Oct 30

重塑治疗格局。撰文丨大眼怪三阴性乳腺癌(TNBC)因其侵袭性强、治疗选择有限且预后差,一直是乳腺癌治疗领域的巨大挑战。近年来,随着免疫治疗技术的迭代、ADC药物的崛起以及多元潜力靶点的持续探索,TNBC治疗格局持续被改写。PD-(L)1疗法,从联合化疗到双抗迭代的新局面近年来,免疫治疗在早期TNBC的新辅助至辅助治疗阶段取得了令人鼓舞的系列成果。以IMpassion-031、KEYNOTE-522...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10